Literature DB >> 153829

Asymmetric septal hypertrophy in patients on long-term hemodialysis.

A S Abbasi, J C Slaughter, M W Allen.   

Abstract

Echocardiographic studies were performed in 23 hypertensive patients who were receiving therapy with long-term hemodialysis. Five patients (22 percent) had normal thickness of the left ventricular wall. Eleven (48 percent) had symmetric left ventricular hypertrophy, and seven (30 percent) showed asymmetric septal hypertrophy, with a ratio of septal to posterior wall thickness of 1.3 or greater. The latter group differed from patients with hypertrophic cardiomyopathy in that patients on long-term hemodialysis had a dilated left ventricular dimension, a relatively normal diastolic slope of the mitral valve, absence of systolic motion of the mitral valve, and a septal to posterior wall ratio of less than 1.5. A high incidence of asymmetric septal hypertrophy in this and other studies indicates that this condition is not specific for hypertrophic cardiomyopathy. We suggest that in addition to asymmetric septal hypertrophy, the diagnosis of hypertrophic cardiomyopathy should be made in the light of the clinical picture, as well as other echocardiographic features.

Entities:  

Mesh:

Year:  1978        PMID: 153829     DOI: 10.1378/chest.74.5.548

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Cardiac performance in various stages of renal failure.

Authors:  S K Pehrsson; R Jonasson; L E Lins
Journal:  Br Heart J       Date:  1984-12

2.  Cardiac effects of chronic renal failure and haemodialysis treatment. Hypertensive versus normotensive patients.

Authors:  M Ikäheimo; K Huttunen; J Takkunen
Journal:  Br Heart J       Date:  1981-06

3.  Spectrum of congenital heart disease detected echocardiographically in prenatal life.

Authors:  L D Allan; D C Crawford; R H Anderson; M Tynan
Journal:  Br Heart J       Date:  1985-11

4.  Cardiac abnormalities in end stage renal failure and anaemia.

Authors:  K P Morris; J R Skinner; C Wren; S Hunter; M G Coulthard
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.